- Research works
- 16 ▼ 93% vs 2013–17
- Citations
- 448 28.4 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 33% world 28%
Not ranked overall: Asper Biotech (Estonia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Asper Biotech (Estonia) publish most on?
By volume in 2022–2025: Genomics and Rare Diseases, Genetic factors in colorectal cancer and Immunodeficiency and Autoimmune Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Genomics and Rare Diseases Genetics 0 works
- 2 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
- 3 Immunodeficiency and Autoimmune Disorders Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Asper Biotech (Estonia)'s research output changed?
Output in 2018–2022 was 93% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tartu
- University of Tartu
- Estonian University of Life Sciences
- Tartu University Hospital
- Tartu Observatory
- Estonian Literary Museum
- Estonian Biocentre
- University of Tartu Natural History Museum and Botanical Garden
- Competence Centre on Health Technologies (Estonia)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.